-
Mashup Score: 16Paper: 24-Hour Urine Testing Does Not Add Value to Multiple Myeloma Response Assessments: A Secondary Analysis of BMT CTN 0702 - 9 day(s) ago
Program: Oral and Poster Abstracts Type: Oral Session: 653. Multiple Myeloma: Clinical and Epidemiological: Decluttering Responses and Dynamic Risk: How Can We Improve Prognostication in Multiple Myeloma? Hematology Disease Topics & Pathways: Research, Clinical trials, Clinical Practice (Health Services and Quality), Clinical Research, Health outcomes research, Plasma Cell Disorders, Diseases, Lymphoid Malignancies 1 University of Washington Fred Hutchinson Cancer Center, Seattle, WA 2 University of
Source: ash.confex.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 24
Program: Oral and Poster Abstracts Type: Oral Session: 653. Multiple Myeloma: Clinical and Epidemiological: Addressing Hematologic and Immune Toxicities and the Status of Quad Therapies Hematology Disease Topics & Pathways: Clinical Practice (Health Services and Quality) Heloise Cheruvalath 1, Anna Clennon 2 *, Asis Shrestha, MD 3 *, Aniko Szabo, PhD 1 *, Vineel Bhatlapenumarthi, MD 4 *, Anannya Patwari, MD 1 *, Metodi Balev 5 *, Divaya Bhutani, MD 6, Sharmilan Thanendrarajan, MD 7, Binod Dhakal, MBBS 8,
Source: ash.confex.comCategories: General Medicine News, Partners & KOLsTweet-
9/ #ASH24 Abstract 256 (Cheruvalath) Preemptive strategy #2 to make BCMA bsAbs safer in #MMsm Don't wait until IgG < 400 (this is myeloma, not rheumatology)... give IVIG now! Or even start IVIG right before bsAb starts... both better than waiting! https://t.co/MZD4Pe9Pwz https://t.co/GrFJktKqPe https://t.co/Qf0rkR4Mq0
-
-
Mashup Score: 24
Program: Oral and Poster Abstracts Type: Oral Session: 653. Multiple Myeloma: Clinical and Epidemiological: Addressing Hematologic and Immune Toxicities and the Status of Quad Therapies Hematology Disease Topics & Pathways: Clinical Practice (Health Services and Quality) Heloise Cheruvalath 1, Anna Clennon 2 *, Asis Shrestha, MD 3 *, Aniko Szabo, PhD 1 *, Vineel Bhatlapenumarthi, MD 4 *, Anannya Patwari, MD 1 *, Metodi Balev 5 *, Divaya Bhutani, MD 6, Sharmilan Thanendrarajan, MD 7, Binod Dhakal, MBBS 8,
Source: ash.confex.comCategories: General Medicine News, Partners & KOLsTweet-
9/ #ASH24 Abstract 256 (Cheruvalath) Preemptive strategy #2 to make BCMA bsAbs safer in #MMsm Don't wait until IgG < 400 (this is myeloma, not rheumatology)... give IVIG now! Or even start IVIG right before bsAb starts... both better than waiting! https://t.co/MZD4Pe9Pwz https://t.co/GrFJktKqPe https://t.co/Qf0rkR4Mq0
-
-
Mashup Score: 3Paper: A Randomized Trial Demonstrates a 3-Shot Flu Vaccine Series Improves Protection over a Single Shot in Multiple Myeloma - 21 day(s) ago
Program: Oral and Poster Abstracts Type: Oral Session: 653. Multiple Myeloma: Clinical a nd Epidemiological: Addressing Hematologic and Immune Toxicities and the Status of Quad Therapies Hematology Disease Topics & Pathways: Research, Clinical trials, Clinical Research 1 Winship Cancer Institute of Emory University, Atlanta, GA 2 Winship Cancer Institute of Emory University, Atlanta Background: In myeloma patients on treatment, there is a 20% risk of influenza-like illness (PMID 25487843, 29427192) and
Source: ash.confex.comCategories: General Medicine NewsTweet-
A Randomized Trial Demonstrates a 3-Shot Flu Vaccine Series Improves Protection over a Single Shot in Multiple Myeloma [Dec 7, 2024] @EagleMyeloma et al. #ASH24 Abst 255 https://t.co/lI4JvZU5ZA #mmsm #IDonc
-
-
Mashup Score: 0Webprogram Unavailable - 21 day(s) ago
Please click HERE if you are not redirected in 5
Source: ash.confex.comCategories: General Medicine NewsTweet-
BMT w/in 4 wks of Sars-Cov-2 Infection Is Associated with Increased Risk of Mortality: A National COVID Cohort Collaborative Study [Sat, Dec 10, 2022] @MeeraMohanMD Abst 387 #ASH22 https://t.co/4MtPzSAUAs #COVID19nCancer #bmtsm #IDonc #COVID19 #AMLsm #leusm OR 49.6
-
-
Mashup Score: 0
Program: Oral and Poster Abstracts Session: 653. Myeloma/Amyloidosis: Therapy, excluding Transplantation: Poster III Hematology Disease Topics & Pathways: Adult, Biological, multiple myeloma, antibodies, Di seases, Therapies, Plasma Cell Disorders, Study Population, Lymphoid Malignancies Niels W.C.J. Van De Donk 1, Sonja Zweegman, MD, PhD 2, Jesus F. San-Miguel, MD, PhD 3, Meletios A Dimopoulos 4, Michele Cavo 5 *, Kenshi Suzuki, MD, PhD 6, Cyrille Touzeau 7 *, Saad Z. Usmani, MD, MBBS, MBA 8, Aurore
Source: ash.confex.comCategories: General Medicine NewsTweet-
Predictive Markers of High-Grade or Serious Tx-Emergent Infections w/ Daratumumab-Based Regimens in NDMM - Van De Donk et al. #ASH20 Abs 3209 https://t.co/E2Jv6ChZMz #mmsm #IDonc The final (MVA) predictive model included age, LDH, albumin & elevated baseline ALT levels (Table) https://t.co/2UjvC7yTxD
-
-
Mashup Score: 1Webprogram Unavailable - 21 day(s) ago
Please click HERE if you are not redirected in 5
Source: ash.confex.comCategories: General Medicine NewsTweet-
2 Dose Series of High-Dose Influenza Vaccine Is Associated with Longer Duration of Serologic Immunity in Patients with Plasma Cell Disorders - Branagan et al. Abstract 438 #ASH17 https://t.co/88IKgohZfY #Flu #mmsm #IDonc
-
-
Mashup Score: 1
Program: Oral and Poster Abstracts Session: 301. Vasculature, Endothelium, Thrombosis and Platelets: Basic and Translational: Poster II Hematology Disease Topics & Pathways: Research, Bleeding and Clotting, Translational Research, Diseases, thrombotic disorders Alexander B Pine, MD, PhD 1, Ayesha Butt, MD 2, Rolando Garcia-Milian, MLS, AHIP 3 *, Sean X Gu, MD, PhD 4 *, Valentina Restrepo, MD 5 *, Yu Pei Chock, MD, MPH 6 *, John Hwa, MD, PhD 7 *, Christopher Tormey, MD 8 *, Henry M Rinder, MD 9, George
Source: ash.confex.comCategories: General Medicine NewsTweet-
Proteomic Profiling of Different Antiphospholipid Antibody-Positive Phenotypes: Results from Antiphospholipid Syndrome Alliance for Clinical Trials & International Networking (APS ACTION) Registry [Dec 10, 2023] @BenignHeme et al #ASH23 Abs 2575 https://t.co/ZESAMWfRkR #APLA #VTE https://t.co/BxEOjdX9iA
-
-
Mashup Score: 17Paper: A 1,000-Genome Map for Multiple Myeloma and Its Precursor Stages, and Its Impact on Clinical Outcome - 2 month(s) ago
Program: Oral and Poster Abstracts Type: Oral Session: 652. MGUS, Amyloidosis, and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Genes, Cells and Algorithms: Novel Methods of Predicting Progression in MGUS and SMM Hematology Disease Topics & Pathways: Research, Translational Research, Bioinformatics, Genomics, Computational biology, Biological Processes, Technology and Procedures, Omics technologies Jean-Baptiste Alberge, PhD 1,2,3, Ankit K. Dutta, PhD 1,2,3 *, Andrea Poletti 1,4
Source: ash.confex.comCategories: General Medicine NewsTweet-
**Basic/Translational Abstracts: - 1019 A 1,000-Genome Map for Multiple Myeloma and Its Precursor Stages, and Its Impact on Clinical Outcome https://t.co/oSbzH0CDX6 -358 Combination with Cytotoxic Therapy and Checkpoint Blockade Overcomes Primary Resistance to BCMA Bispecific… https://t.co/MTRou3ET7G
-
-
Mashup Score: 0Webprogram Unavailable - 2 month(s) ago
Please click HERE if you are not redirected in 5
Source: ash.confex.comCategories: General Medicine NewsTweet-
RCT of Primary Prophylaxis w/ Weekly Alendronate Against Glucocorticoid-Induced Osteoporosis in Lymphoma Pts Treated w/ Steroid-Containing Chemotherapy [Dec 12, 2021] Jensen et al. Abstract 456 #ASH21 https://t.co/5hoV9HpqQh #lymsm #BoneHealth #SuppOnc HT @graham74GC
-
4/ #ASH24 Abstract 81 (Banerjee) [COI: I'm very passionate about this!] Urine-free IMWG response criteria (without 24-hr urines in fridge) worked just fine in @BMTCTN 0702. ⬇️ pt discomfort, ⬇️ #MMsm study deviations. The p-value of pee is minimal! https://t.co/O4oWoHsswO https://t.co/QFS3BIXn8y https://t.co/bqWIIxZj3E